Next Gen Digital Diagnostic Platform to Detect Multiple Pathogens within 5 Minutes at Gene Level
|
By HospiMedica International staff writers Posted on 30 Jun 2023 |
|
An advanced digital diagnostic platform with the capability to detect multiple pathogens in five minutes at the molecular gene level and priced significantly lower than current molecular tests is all set to disrupt the PCR market.
Check4 by IdentifySensors Biologics (Cleveland, OH, USA) is a next-generation digital diagnostic platform that has been developed to detect the genetic material of a wide range of pathogens for over-the-counter and point-of-care use. The Check4 testing platform comprises two components: a reusable Bluetooth reader roughly the size of a mobile phone, and disposable test cartridges that connect to the reader. Each test sample can simultaneously detect up to three different pathogens. Digital graphene sensors within the cartridges target conserved regions of the genome, thereby ensuring high sensitivity and specificity without the need for enzymatic amplification or reagents.
The sensors in the disposable cartridges can be customized to identify a broad range of pathogens that display similar symptoms. Multiplex tests are in development for respiratory pathogens (COVID, RSV, and influenza), gastrointestinal pathogens (Norovirus, Rotavirus, and Adenovirus), and sexually transmitted pathogens (HIV, Hepatitis, Chlamydia, Gonorrhea, and Herpes). Other tests under development include those for SEPSIS, MRSA, Lyme disease, and tropical pathogens such as Zika, Dengue, Yellow Fever, and West Nile virus. Previous research indicates that Check4 can potentially diagnose infections like COVID, RSV, and influenza even before patients exhibit symptoms. IdentifySensors has commenced testing this novel diagnostic device in anticipation of FDA submissions. Clinical studies for the Check4 diagnostic device are slated for this year as part of an extensive testing platform designed to be adapted for detecting a broad range of additional pathogens in the coming years.
"In preliminary studies we have seen encouraging results of this new technology," said Greg Hummer M.D., IdentifySensors co-founder and CEO. "We are excited to test these devices and move forward with additional targets that detect a wide range of infections."
Related Links:
IdentifySensors Biologics
Latest Point of Care News
- Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
- Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
- Ultrathin Metasurface Could Bring Quantitative Phase Imaging to Portable Devices
- Rapid Onsite Testing Reduces Emergency Department Transfers in Long-Term Care
- New Brain Ultrasound Platform Enables Bedside Postoperative Imaging
- Handheld Ultrasound Expands Point-of-Care Imaging Access in Brazil
- AI Dermatology Platform Targets Early Detection of Non-Melanoma Skin Cancer
- Handheld AI Device for Point-of-Care Skin Lesion Assessment Receives CE Mark
- Portable Immunoassay System Advances Toward Point-of-Care Biomarker Testing
- Portable MRI System Accelerates Emergency Brain Imaging and Triage
- Point-of-Care Viscoelastic Testing System Supports Obstetric Bleeding Management
- Portable MRI System Gains CE Mark for Point-of-Care Brain Imaging
Channels
Artificial Intelligence
view channel
AI Tool Predicts Long-Term Cardiovascular Risk from Sleep Study ECG
Sleep disorders such as insomnia and obstructive sleep apnea are established cardiovascular risk factors and are commonly evaluated with overnight polysomnography. These studies routinely record electrocardiogram... Read more
Predictive Model Supports Growth Hormone Treatment Planning in Idiopathic Short Stature
Idiopathic short stature (ISS) describes children whose height is substantially below the expected range for age and sex without an identifiable medical cause. Recombinant growth hormone therapy can support... Read more
Critical Care
view channel
Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery
Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more
AI Tool Combining ECG and Blood Tests Reduces Unnecessary Heart Transplant Biopsies
Cardiac transplant rejection occurs when a recipient’s immune system attacks a donated heart. Diagnosis currently relies on biopsy, an invasive procedure in which heart muscle tissue is removed and examined... Read more
Deep Brain Stimulation Window May Matter for Parkinson’s Patients With GBA1 Variants
Patients with GBA1 gene variants may develop significant physical symptoms earlier in life while also facing greater vulnerability to cognitive problems. This combination can complicate decisions about... Read more
FDA-Approved App Enables Pulmonary Pressure Monitoring and Medication Guidance in Heart Failure
Heart failure is a chronic, progressive condition and a leading cause of hospitalization, with clinical status often deteriorating before symptoms appear. Rising pulmonary artery pressure can precede decompensation... Read moreSurgical Techniques
view channel
Contact Radiotherapy Offers New Organ-Preserving Approach for Rectal Cancer
Tampere University Hospital, known as Tays, is the first hospital in Finland to introduce contact radiotherapy for rectal cancer using high-dose-rate brachytherapy, or HDR brachytherapy.... Read more
Covered Stent System Achieves High Nine-Month Patency in Iliac Artery Disease
Iliac artery disease, a common form of peripheral artery disease, can restrict blood flow to the legs and impair mobility and quality of life. Clinicians continue to seek durable endovascular treatments... Read more
Patient Care
view channel
AI Platform Personalizes Support Between Visits for Cancer Survivors
Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more
At-Home Neuromodulation Shows Promise in Selected Patients With Hypertension
High blood pressure is a major risk factor for cardiovascular disease, including heart attack and stroke. Many patients receiving treatment for hypertension still remain above recommended blood pressure... Read more
EHR Model Flags High-Risk Periods in Patients with Metastatic Breast Cancer
Determining when patients with metastatic breast cancer are nearing the end of life remains difficult, often leading to intensive interventions with limited benefit. Prognostic uncertainty can delay goals-of-care... Read more
Medical Imaging
view channel
Public Chest CT Dataset Supports Explainable AI in Diagnostic Radiology
Chest computed tomography scans generate complex three-dimensional images that can be difficult for artificial intelligence systems to explain clearly. Clinicians need to verify AI findings before using... Read more
PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI
Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more
AI Software Detects Osteoporosis from Routine CT Scans
Osteoporosis can progress for years without pain, leaving bone loss undetected until a fracture or back pain prompts testing. By that point, bone loss may already be advanced. Bone density testing is not... Read more
AI Model Uses Pretreatment CT Scans to Predict Immunotherapy-Related Pneumonitis Risk
Pneumonitis is a potentially life-threatening form of lung inflammation that affects about 10% of patients with lung cancer receiving immunotherapy. Because it can be difficult to predict before symptoms... Read moreHealth IT
view channel
EHR Alerts Support Dosing, Sedation, and Shock Recognition in Cardiac Care
Electronic health record alerts can add to clinician workload when they are poorly targeted. In critical cardiac care, however, delayed decisions can affect treatment timing, sedation exposure, and escalation... Read more
Adaptive Radiation QA Software Gains Validation for NeoArc Treatments
Adaptive radiation therapy allows clinicians to adjust treatment plans to daily anatomical changes such as tumor shrinkage, weight loss, or organ movement, improving precision while limiting exposure to... Read more
Business
view channel
Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma
Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition
World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery
As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more